Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA Title Grant Type Focus Area Country Application Due Date Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFPRelease Date:Quality Improvement Inflammation & Immunology Canada, USA ADVANCE: Global Awards for Advancing Chronic Pain ResearchResearch Internal Medicine All Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 EraRelease Date:Quality Improvement Inflammation & Immunology United Kingdom New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)Release Date:Partner: Merck KGaA Darmstadt, Germany and EMD SeronoEducation Oncology France, Germany, Italy, Spain, USA, United Kingdom Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology USA Remote Mentoring Programs in RCCRelease Date:Education Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology All Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)Release Date:Partner: The Sharing Progress in Cancer Care (SPCC)Quality Improvement Oncology All Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)Release Date:Education Inflammation & Immunology Canada, USA NSCLC Oncogene Driver Considerations in Testing & TreatmentRelease Date:Education Oncology USA Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision MakingRelease Date:Education Oncology Canada, USA Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology France, Germany